Through this award, the initiators have been supporting oral health research for years and promoting young professionals in the early stages of their research careers – also by making them part of a worldwide network of clinicians and scientists.
2023 SCADA Award Winning Projects
In the Clinical Science & Public Health Research category:
- 1st Place: Jay Dalal, University of Connecticut, School of Dental Medicine, won the competition with his research project “The Effectiveness of Current Desensitizing Agents at Hypersensitivity Prevention”.
- 2nd Place: Julia Kishanie Persaud, New York University, College of Dentistry, project: The Impact of Electronic Cigarette Use on the Salivary Microbiome in Periodontitis Patients
- 3rd Place: Mackenzie Andrews, Midwestern University, project: Does Mouthguard Lamination Technique affect Hockey and Baseball Impact Force?
In the Basic & Translational Science category:
- 1st Place: Natalie Andras from The Ohio State University, College of Dentistry, is the winner with her project “Gene-Editing Provides Functional Evidence for the Ectomesenchymal Origin of Cementoblasts”.
- 2nd Place: W. Benton Swanson, University of Michigan, project Scaffold-based Approach to Regenerating the Cranial Suture Stem Cell Niche
- 3rd Place: Darnell Cuylear, University of California, San Francisco, project: Calcium Phosphate Microparticles For Dual Anti-resorptive Drug Delivery and Osteogenesis
First, second and third winning projects in each of the two categories were awarded with $1,000 for 1st place, $750 for 2nd, and $500 for 3rd.
SCADA – a program dedicated to research and international networking
SCADA was initiated in 1959 and is committed to two main goals: to strengthen the field of dental research by supporting young professionals in early stages of their research careers, and to promote networking between students and clinicians and scientists from all over the world as they develop their skills and advance their careers. Dentsply Sirona and the American Association for Dental, Oral and Craniofacial Research support this program as co-sponsors, engaging over 7,000 students worldwide, to showcase their research, recognize their passion for discovery and innovation, and fuel the future of dental care.
In addition to the US competition, the SCADA program also has an international component. Dentsply Sirona sponsored 6 other national student research competitions in France, Germany, Japan, South Korea, Taiwan, and Thailand in 2022. With Dentsply Sirona’s support, the student winners of each country were invited to present their winning research on a non-competitive manner at the AADOCR/CADR Annual Meeting.
SCADA advances science and improves global oral health
“Our vision at Dentsply Sirona is to transform dentistry and to improve oral health globally. This is just possible with science. What better way to help guide the future of the profession and oral health than to support science in its foundations. The student clinicians are the future of oral science, and we are committed to investing into this future by running the SCADA program in the last 64 years.” said Dr. Rainer Seemann, Vice President Global Clinical Research with Dentsply Sirona.
“It’s a pleasure to recognize and celebrate our new, talented scientists in the oral health space,” said AADOCR President Jane Weintraub. “These accomplished SCADA investigators provide an auspicious future for dental, oral, and craniofacial research.”
DISCLAIMER
This information and any attachment thereto contains “forward-looking statements” within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are not guarantees of future performance. These forward-looking statements reflect views and assumptions regarding expectations and projections about future events and are based on currently available information or information available on the date of any document incorporated by reference. You can generally identify these forward-looking statements by the use of words such as "may," "could," "estimate," "will," "believe," "anticipate," "think," "intend," "expect," "project," "plan," "target," "forecast", and similar words and expressions. However, these words are not the exclusive means of identifying such statements. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances are forward-looking statements and may include statements relating to future revenues, expenses, margins, profitability, net income/(loss), earnings per share and other measures of results of operations and the prospects of future growth of our business. These forward-looking statements are inherently subject to uncertainties, risks and changes in circumstances that are difficult to predict. For a discussion of such risks, uncertainties and other matters that could cause actual results to differ materially, including risks relating to, among other factors, the market for dental products and services, pricing, future sales volume of the Company’s products, the possibility of changing economic, market and competitive conditions, dependence on products, dependence on key personnel, technological developments, intense competition, market uncertainties, dependence on distributors, ability to manage growth, dependence on key suppliers, dependence on key members of management, government regulation, our ability to integrate the businesses of Dentsply Sirona, acquisitions and affiliations, readers are urged to carefully review and consider various disclosures made by the Company and Dentsply Sirona in their public filings, including in their Annual Reports on Form 10-K and in their reports on Forms 10-Q and 8-K filed with the Securities and Exchange Commission.
Readers are cautioned not to place undue reliance on such statements, which speak only as of the date hereof. Except as required by law, the Company does not assume any obligation to update any forward-looking statements contained in this document or the attachments to reflect new information or future events or developments after the date any such statement is made.
Dentsply Sirona is the world’s largest manufacturer of professional dental products and technologies, with over a century of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solution offering, including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. Dentsply Sirona’s products provide innovative, high-quality and effective solutions to advance patient care and deliver better and safer dental care. Dentsply Sirona’s headquarters are located in Charlotte, North Carolina. The company’s shares are listed in the United States on NASDAQ under the symbol XRAY. Visit www.dentsplysirona.com for more information about Dentsply Sirona and its products.
Dentsply Sirona Deutschland GmbH
Fabrikstraße 31
64625 Bensheim
Telefon: +49 (6251) 16-0
Telefax: +49 (6251) 16-2591
http://dentsplysirona.com
PR Manager
Telefon: +43 (662) 2450-588
E-Mail: marion.weixlberger@sirona.com
Pressekontakt
Telefon: +49 (69) 509546339
E-Mail: dentsplysirona@edelman.com